BioPoly, based in Fort Wayne, Indiana, manufactures several biomaterial products that orthopaedic surgeons can use to resurface areas of the knee, patella and shoulder when they become worn down.
Current surgical treatments for painful, debilitating articular cartilage defects lie between two extremes: biological attempts and artificial replacement. However, many patients are not suitable candidates for the biological techniques, and may not yet be needing such invasive surgery to insert a complete artificial joint.
The BioPoly ReSurfacing devices provide a treatment option between these extremes. Utilising a patented material that is self-lubricating for improved wear properties, the BioPoly® devices are uniquely designed to replace only the damaged cartilage. Therefore, patients can quickly recover and return to pain-free, active lifestyles.
Phil Davies, founder and managing director of Hospital Innovations, said: “We are thrilled to have signed an exclusive distribution deal with BioPoly. To be the sole distributor of these ground-breaking products is testament to the trust the company has in us.
“These unique products will help ensure patients can quickly recover and return to pain-free, active lifestyles; and we are looking forward to seeing the effect these will have on the lives of patients in the UK.”
Herb Schwartz, BioPoly president said: “We at BioPoly are very excited to be partnering with Hospital Innovations in the UK. Their knowledgeable and experienced team will represent BioPoly’s growing product portfolio very well as they expand the market and provide the best service to the UK orthopaedic surgeon customers”
Hospital Innovations specialises in creating innovative, safe and effective solutions to hospitals and clinics; and has grown into a globally trading company.